&nbsp;

Breast-Cancer-Screening-for-People-Ages-40-to-49_Moose-Cree.pdf

New

May 2025

Document

Breast-Cancer-Screening-for-People-Ages-40-to-49_Swampy-Cree.pdf

New

May 2025

Breast Cancer Screening for People Ages 40 to 49: What You Need to Know

In October 2024, the Ontario Breast Screening Program lowered the starting age for screening from age 50 to age 40.This page provides breast cancer...

Regimen

BICALPRL

Cancer Type:

Genitourinary,

Prostate

Intent: Neoadjuvant, Adjuvant, Palliative

Funding:

ODB - General Benefit

leuprolide - long-acting formulation

ODB - General Benefit

bicalutamide

Drugs Used:

leuprolide,

bicalutamide

Quick Link(s):

Regimen Monograph

May 2025

Document

Taking-Care-of-Someone-Who-is-ill.pdf

New

Jun 2025

Document

Taking-Care-of-Someone-Who-is-ill-thumbnail.jpg

New

Jun 2025

Drug

trametinib

Other Name(s): Mekinist®

Quick Link(s): Drug Monograph, Patient Info Sheet

Jun 2025

Regimen

TRAM

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

Exceptional Access Program

trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria

Drugs Used:

trametinib

Quick Link(s):

Regimen Monograph

Jun 2025

Drug

brentuximab vedotin

Other Name(s): Adcetris®

Quick Link(s): Drug Monograph, Patient Info Sheet

Jun 2025

Regimen

BELZ

Cancer Type:

Endocrine,

Pancreatic Neuroendocrine,

Genitourinary,

Renal cell / Kidney

Intent: Curative, Palliative

Funding:

Exceptional Access Program

Belzutifan – For the treatment of adult patients with von Hippel-Lindau (VHL) disease, based on criteria

Drugs Used:

belzutifan

Quick Link(s):

Regimen Monograph

Jun 2025

Document

trousse-outils-sur-cancer-depistage-print.pdf

New

Jun 2025

Regimen

TOPO(W)

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

topotecan